IBDEI21B ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32473,1,4,0)
 ;;=4^H35.041
 ;;^UTILITY(U,$J,358.3,32473,2)
 ;;=^5005594
 ;;^UTILITY(U,$J,358.3,32474,0)
 ;;=H35.042^^128^1661^29
 ;;^UTILITY(U,$J,358.3,32474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32474,1,3,0)
 ;;=3^Retinal Micro-Aneurysms,Unspec,OS
 ;;^UTILITY(U,$J,358.3,32474,1,4,0)
 ;;=4^H35.042
 ;;^UTILITY(U,$J,358.3,32474,2)
 ;;=^5005595
 ;;^UTILITY(U,$J,358.3,32475,0)
 ;;=H35.053^^128^1661^33
 ;;^UTILITY(U,$J,358.3,32475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32475,1,3,0)
 ;;=3^Retinal Neovascularization,Unspec,OU
 ;;^UTILITY(U,$J,358.3,32475,1,4,0)
 ;;=4^H35.053
 ;;^UTILITY(U,$J,358.3,32475,2)
 ;;=^5005600
 ;;^UTILITY(U,$J,358.3,32476,0)
 ;;=H35.051^^128^1661^31
 ;;^UTILITY(U,$J,358.3,32476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32476,1,3,0)
 ;;=3^Retinal Neovascularization,Unspec,OD
 ;;^UTILITY(U,$J,358.3,32476,1,4,0)
 ;;=4^H35.051
 ;;^UTILITY(U,$J,358.3,32476,2)
 ;;=^5005598
 ;;^UTILITY(U,$J,358.3,32477,0)
 ;;=H35.052^^128^1661^32
 ;;^UTILITY(U,$J,358.3,32477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32477,1,3,0)
 ;;=3^Retinal Neovascularization,Unspec,OS
 ;;^UTILITY(U,$J,358.3,32477,1,4,0)
 ;;=4^H35.052
 ;;^UTILITY(U,$J,358.3,32477,2)
 ;;=^5005599
 ;;^UTILITY(U,$J,358.3,32478,0)
 ;;=H35.073^^128^1661^36
 ;;^UTILITY(U,$J,358.3,32478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32478,1,3,0)
 ;;=3^Retinal Telangiectasis,OU
 ;;^UTILITY(U,$J,358.3,32478,1,4,0)
 ;;=4^H35.073
 ;;^UTILITY(U,$J,358.3,32478,2)
 ;;=^5005608
 ;;^UTILITY(U,$J,358.3,32479,0)
 ;;=H35.071^^128^1661^34
 ;;^UTILITY(U,$J,358.3,32479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32479,1,3,0)
 ;;=3^Retinal Telangiectasis,OD
 ;;^UTILITY(U,$J,358.3,32479,1,4,0)
 ;;=4^H35.071
 ;;^UTILITY(U,$J,358.3,32479,2)
 ;;=^5005606
 ;;^UTILITY(U,$J,358.3,32480,0)
 ;;=H35.072^^128^1661^35
 ;;^UTILITY(U,$J,358.3,32480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32480,1,3,0)
 ;;=3^Retinal Telangiectasis,OS
 ;;^UTILITY(U,$J,358.3,32480,1,4,0)
 ;;=4^H35.072
 ;;^UTILITY(U,$J,358.3,32480,2)
 ;;=^5005607
 ;;^UTILITY(U,$J,358.3,32481,0)
 ;;=H34.03^^128^1661^23
 ;;^UTILITY(U,$J,358.3,32481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32481,1,3,0)
 ;;=3^Transient Retinal Artery Occlusion,OU
 ;;^UTILITY(U,$J,358.3,32481,1,4,0)
 ;;=4^H34.03
 ;;^UTILITY(U,$J,358.3,32481,2)
 ;;=^5005555
 ;;^UTILITY(U,$J,358.3,32482,0)
 ;;=H34.01^^128^1661^21
 ;;^UTILITY(U,$J,358.3,32482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32482,1,3,0)
 ;;=3^Transient Retinal Artery Occlusion,OD
 ;;^UTILITY(U,$J,358.3,32482,1,4,0)
 ;;=4^H34.01
 ;;^UTILITY(U,$J,358.3,32482,2)
 ;;=^5005553
 ;;^UTILITY(U,$J,358.3,32483,0)
 ;;=H34.02^^128^1661^22
 ;;^UTILITY(U,$J,358.3,32483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32483,1,3,0)
 ;;=3^Transient Retinal Artery Occlusion,OS
 ;;^UTILITY(U,$J,358.3,32483,1,4,0)
 ;;=4^H34.02
 ;;^UTILITY(U,$J,358.3,32483,2)
 ;;=^5005554
 ;;^UTILITY(U,$J,358.3,32484,0)
 ;;=H35.00^^128^1661^47
 ;;^UTILITY(U,$J,358.3,32484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32484,1,3,0)
 ;;=3^Background Retinopathy,Unspec
 ;;^UTILITY(U,$J,358.3,32484,1,4,0)
 ;;=4^H35.00
 ;;^UTILITY(U,$J,358.3,32484,2)
 ;;=^5005581
 ;;^UTILITY(U,$J,358.3,32485,0)
 ;;=H34.823^^128^1661^50
 ;;^UTILITY(U,$J,358.3,32485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32485,1,3,0)
 ;;=3^Venous Engorgement,OU
 ;;^UTILITY(U,$J,358.3,32485,1,4,0)
 ;;=4^H34.823
